These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37198205)

  • 1. Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice.
    Lu Z; Liu L; Zhao S; Zhao J; Li S; Li M
    Sci Rep; 2023 May; 13(1):7996. PubMed ID: 37198205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
    Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
    J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
    Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
    Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
    Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
    Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.
    Wang Q; Ou Y; Hu G; Wen C; Yue S; Chen C; Xu L; Xie J; Dai H; Xiao H; Zhang Y; Qi R
    Br J Pharmacol; 2020 Apr; 177(8):1806-1821. PubMed ID: 31758699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
    Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
    Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.
    Xiang R; Liu Y; Fan L; Jiang B; Wang F
    Lab Invest; 2022 Oct; 102(10):1088-1100. PubMed ID: 35690649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway.
    Wu Y; Zhou J; Zuo X; Kuang Y; Sun L; Zhang X
    Chin J Nat Med; 2024 Mar; 22(3):224-234. PubMed ID: 38553190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
    Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
    Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
    Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
    Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation.
    Zhang ZT; He WJ; Deng SM; Xu SH; Zeng X; Qian ZM; Chen ZQ; Wang SM; Tang D
    Eur J Pharmacol; 2022 Oct; 933():175291. PubMed ID: 36150533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
    Yan J; Li M; Wang XD; Lu ZY; Ni XL
    Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway.
    Huang Y; Wan T; Pang N; Zhou Y; Jiang X; Li B; Gu Y; Huang Y; Ye X; Lian H; Zhang Z; Yang L
    J Cell Physiol; 2019 Nov; 234(11):21224-21234. PubMed ID: 31032942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
    Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
    Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
    Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
    J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
    Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
    Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways.
    Yong Z; Ruiqi W; Hongji Y; Ning M; Chenzuo J; Yu Z; Zhixuan X; Qiang L; Qibing L; Weiying L; Xiaopo Z
    J Immunol Res; 2021; 2021():4084566. PubMed ID: 34734090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.